Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis

Clinical trial NCT02068339 · COMPLETED

Trial details

NCT number: NCT02068339
Sponsor: PharmaKing
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-alcholic Fatty Liver Disease

Start date: 2014-02-01
Primary completion: 2016-02-01
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.